About Early-onset progressive leukoencephalopathy-central nervous system calcification-deafness-visual impairment syndrome
Early-onset progressive leukoencephalopathy-central nervous system calcification-deafness-visual impairment syndrome is a rare disease catalogued by Orphanet (ORPHA:3240). It is associated with the KARS1 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Early-onset progressive leukoencephalopathy-central nervous system calcification-deafness-visual impairment syndrome trials.
Search ClinicalTrials.gov for "Early-onset progressive leukoencephalopathy-central nervous system calcification-deafness-visual impairment syndrome" or filter by Orphanet code ORPHA:3240 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Early-onset progressive leukoencephalopathy-central nervous system calcification-deafness-visual impairment syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Early-onset progressive leukoencephalopathy-central nervous system calcification-deafness-visual impairment syndrome. Updated daily.